Giuseppe
Emeritus
[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]
Sci Transl Med. 2014 May 7;6(235):235fs19. doi: 10.1126/scitranslmed.3009132.
Neutralizing the MERS Coronavirus Threat.
Haagmans BL<SUP>1</SUP>, M E Osterhaus AD.
Author information: <SUP>1</SUP>Department of Viroscience, Erasmus Medical Center, 3000 CA Rotterdam, the Netherlands.
Abstract
Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
PMID: 24807556 [PubMed - in process]
-
------
Sci Transl Med. 2014 May 7;6(235):235fs19. doi: 10.1126/scitranslmed.3009132.
Neutralizing the MERS Coronavirus Threat.
Haagmans BL<SUP>1</SUP>, M E Osterhaus AD.
Author information: <SUP>1</SUP>Department of Viroscience, Erasmus Medical Center, 3000 CA Rotterdam, the Netherlands.
Abstract
Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
PMID: 24807556 [PubMed - in process]
-
------